Shandong Weigao Group Medical Polymer Company Limited (HKG: 1066)

Market Cap	19.65B
Revenue (ttm)	13.93B
Net Income (ttm)	2.05B
Shares Out	4.57B
EPS (ttm)	0.45
PE Ratio	9.54
Forward PE	8.04
Dividend	0.18 (4.36%)
Ex-Dividend Date	Oct 18, 2024

Volume	10,373,697
Open	4.280
Previous Close	4.210
Day's Range	4.180 - 4.340
52-Week Range	3.600 - 8.020
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Shandong Weigao Group Medical Polymer Company

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 12,519
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1066

Financial Performance

In 2023, Shandong Weigao Group Medical Polymer Company's revenue was 13.23 billion, a decrease of -3.77% compared to the previous year's 13.75 billion. Earnings were 2.00 billion, a decrease of -27.57%.

Financial numbers in CNY